台湾13价肺炎球菌结合疫苗补种免疫规划的影响:聚焦年龄分层差异与高危人群(2001-2015)
台湾于2013年对2-5岁儿童、2014年对1-5岁儿童开展13价肺炎球菌结合疫苗(PCV13)国家补种规划。该研究利用2001年1月至2015年12月全民健康保险研究数据库,采用中断时间序列分析评估该规划对总体及高危人群全因肺炎和肺炎球菌肺炎发病率的影响,发现2-4岁儿童肺炎球菌肺炎发病率显著下降,未接种儿童中也观察到间接保护,但多数高危人群未见显著影响。
要点
- 2-4岁儿童肺炎球菌肺炎发病率水平变化为每10万人季度-10.56(p=0.04),趋势变化为-2.93(p<0.01)。
- 未接种儿童(0-1岁、5-9岁、10-17岁)中观察到间接保护。
- 多数高危人群未发现显著影响。
核心结论
- 研究提示,引入PCV13补种规划与接种儿童中肺炎球菌肺炎和全因肺炎发病率的显著下降相关,未接种儿童中也发现了该规划的间接保护。
研究设计与样本
- 利用台湾全民健康保险研究数据库(NHIRD)2001年1月至2015年12月的数据,采用中断时间序列分析,按年龄分层(0-1、2-4、5-9、10-17、18-34、35-49、50-64、65岁以上)评估总体和高危人群中肺炎球菌肺炎及全因肺炎的发病率(每10万人季度)。
主要发现
- 2-4岁儿童肺炎球菌肺炎发病率水平变化为每10万人季度-10.56(p=0.04),趋势变化为-2.93(p<0.01)。
- 未接种儿童中,0-1岁趋势变化为-1.19(p=0.01),5-9岁趋势变化为-1.04(p=0.03),10-17岁水平变化为每10万人季度-1.42(p=0.03)。
- 2-4岁儿童全因肺炎发病率水平变化为每10万人季度-234.91(p=0.058),5-9岁儿童为每10万人季度-173.96(p=0.0424)。
- 多数高危人群未发现显著影响。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Taiwan commenced a national catch-up immunization program with a 13-valent pneumococcal conjugate vaccine (PCV13) in 2013 for children aged 2-5 years old and in 2014 for children aged 1-5 years old. However, real-world nationwide evidence of both the direct protection and indirect protection of all-cause pneumonia and pneumococcal pneumonia has been scarce, especially among high-risk populations, defined as patients with chronic diseases or immunosuppression. The aim of this study was to examine the impact of the national PCV13 catch-up program on all-cause pneumonia and pneumococcal pneumonia among overall and high-risk populations using interrupted time series analysis. METHODS: Using the National Health Insurance Research Database (NHIRD) from January 2001 to December 2015, we assessed the impact of this catch-up program by interrupted time-series analyses age-stratified (0-1, 2-4, 5-9, 10-17, 18-34, 35-49, 50-64, 65 + years old) incidence of pneumococcal pneumonia and all-cause pneumonia (100,000 person-quarter) among the overall and high-risk populations. RESULTS: The impact of this program was most profound on the incidence of pneumococcal pneumonia in children aged 2-4 years old (level change -10.56 per 100,000 person-quarters, p = 0.04; trend change -2.93, p less than 0.01). Indirect protection among unvaccinated children (0-1 years old: trend change -1.19, p = 0.01; 5-9 years old: trend change -1.04, p = 0.03; 10-17 years old: level change -1.42 per 100,000 person-quarters, p = 0.03) was also found. The incidence of all-cause pneumonia also decreased in children aged 2-4 (level change -234.91 per 100,000 person-quarter, p = 0.058) and 5-9 years old (level change -173.96 per 100,000 person-quarter, p = 0.0424). However, we did not find a significant impact among most high-risk populations. CONCLUSIONS: Our study suggests that the introduction of this catch-up program with PCV13 was associated with significant declines in the incidence of pneumococcal pneumonia and all-cause pneumonia in vaccinated children, and indirect protection from the program was also found in unvaccinated children.
引用
- Huang ST, Huang YC, Kuo E, et al. Impacts of Catch-Up Immunization program with the 13-Valent pneumococcal Conjugate vaccine in Taiwan: Focus on age-stratified differences and high-risk population (2001-2015). Vaccine. 2022. PMID: 36127209. doi:10.1016/j.vaccine.2022.09.002
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。